CLEC9A is reported to induce antitumor responses55,56 and modulate cytotoxic T lymphocyte responses to virus infection in mice57,58; however, the mechanisms underlying the influence of EBV infection on the CLEC9A+ DC-related immune response in NPC remain to be elucidated. This evidence concerns the gene CLEC9A and nasopharyngeal carcinoma.